1. Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism. (17th September 2013) Authors: Hill, T D M; Cascio, M‐G; Romano, B; Duncan, M; Pertwee, R G; Williams, C M; Whalley, B J; Hill, A J Journal: British journal of pharmacology Issue: Volume 170:Number 3(2013:Oct.) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP018 High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling. (16th January 2018) Authors: Mascaraque, C; Elangovan, S; Petti, L; Piontini, A; Correale, C; Arena, V; Romano, B; Ungaro, F; Garlatti, V; D'Alessio, S; Fiorino, G; Spinelli, A; Danese, S; Vetrano, S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. (12th April 2013) Authors: Romano, B; Borrelli, F; Fasolino, I; Capasso, R; Piscitelli, F; Cascio, MG; Pertwee, RG; Coppola, D; Vassallo, L; Orlando, P; Di Marzo, V; Izzo, AA Journal: British journal of pharmacology Issue: Volume 169:Number 1(2013:May) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗